Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,134 | 4,812 | 8,193 | 10,938 | 3,977 |
| Cost of Goods | 41 | 8,391 | N/A | N/A | N/A |
| Gross Profit | 2,093 | -3,579 | 8,193 | 10,938 | 3,977 |
| Operating Expenses | 68,949 | 111,951 | 200,009 | 102,122 | 30,676 |
| Operating Income | -66,815 | -115,139 | -191,816 | -91,184 | -26,699 |
| Other Income | 4,808 | 2,127 | -220 | 54 | -775 |
| Pre-tax Income | -62,007 | -113,012 | -192,036 | -91,130 | -27,474 |
| Net Income Continuous | -62,007 | -113,012 | -192,036 | -91,130 | -27,474 |
| Net Income | $-62,007 | $-113,012 | $-192,036 | $-91,130 | $-27,474 |
| EPS Basic Total Ops | -34.12 | -62.77 | -127.14 | -644.38 | 514.84 |
| EPS Basic Continuous Ops | -34.12 | -62.77 | -127.08 | -644.37 | -536.08 |
| EPS Diluted Total Ops | -34.12 | -62.77 | -127.14 | -644.38 | -191.45 |
| EPS Diluted Continuous Ops | -34.12 | -62.77 | -127.08 | -644.37 | -191.53 |
| EPS Diluted Before Non-Recurring Items | -34.12 | -63.57 | -127.14 | N/A | N/A |
| EBITDA(a) | $-66,045 | $-106,309 | $-190,238 | $-90,421 | $-25,973 |